市场调查报告书
商品编码
1519380
2024-2032 年按产品、细胞类型、技术、应用、最终用户和地区分類的细胞分离技术市场报告Cell Separation Technologies Market Report by Product, Cell Type, Technology, Application, End User, and Region 2024-2032 |
IMARC Group年,全球细胞分离技术市场规模达104亿美元。製药和生物技术领域越来越多地采用细胞分离技术、对个人化医疗的需求不断增长以及行业持续的技术进步是推动市场的一些关键因素。
细胞分离技术或细胞隔离技术是指用于从异质细胞混合物中分离特定细胞的一系列方法和技术。一些标准技术包括微流体细胞分选、萤光活化细胞分选 (FACS)、免疫原性细胞分离、磁活化细胞分选 (MACS) 和密度梯度配置。细胞分离技术有助于分离罕见的肿瘤细胞或干细胞,用于进一步分析和治疗目的。因此,它们被广泛用于医疗保健和生物技术行业的研究、临床和工业应用,例如疾病诊断、药物发现和生物加工。除此之外,细胞分离技术对于研究细胞异质性以了解疾病机制和开发个人化药物至关重要。
整个製药业越来越多地使用细胞分离技术来增强药物发现和开发程序,这是推动市场成长的主要因素。与此一致的是,癌症、后天免疫缺乏症候群(爱滋病)和囊性纤维化等多种慢性和传染病的日益普及正在推动市场成长。此外,对个人化和再生医学的需求不断增长,推动了对高度特异性细胞分离技术的需求,这些技术可以分离特定的细胞类型以进行标靶治疗。除此之外,细胞分离技术在生产多种疾病疫苗中的广泛应用,包括人类乳突病毒(HPV)、流感和轮状病毒,正在为市场创造良好的前景。除此之外,在蓬勃发展的生物技术领域对研发(R&D)计划的广泛投资,以开发新型细胞疗法和治疗方法,也促进了市场的成长。同时,对干细胞研究的高度关注、体外诊断需求的激增以及各国政府为改善医疗基础设施而采取的众多有利倡议的实施都有助于市场扩张。此外,细胞分离技术(例如微流体、晶片实验室和微阵列技术)的不断进步,为市场带来了有利可图的成长机会。此外,先进的分离工具的出现可以连续检查核酸、染色质、蛋白质和其他复杂细胞,这正在成为另一个重要的生长诱导因素。
The global cell separation technologies market size reached US$ 10.4 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 33.9 Billion by 2032, exhibiting a growth rate (CAGR) of 13.7% during 2024-2032. The rising adoption of cell separation technologies across the pharmaceutical and biotechnology sectors, the growing demand for personalized medicine, and ongoing technological advancements in the industry represent some of the key factors driving the market.
Cell separation technologies, or cell isolation technologies, refer to a range of methods and techniques used to isolate specific cells from a heterogeneous mixture of cells. Some of the standard techniques include microfluidic cell sorting, fluorescence-activated cell sorting (FACS), immunogenicity cell isolation, magnetic-activated cell sorting (MACS), and density gradient configuration. Cell separation technologies help isolate rare tumor cells or stem cells for further analysis and therapeutic purposes. As a result, they are used across the healthcare and biotechnology industries for research, clinical, and industrial applications, such as disease diagnosis, drug discovery, and bioprocessing. In addition to this, cell separation technologies are essential for studying cellular heterogeneity to understand disease mechanisms and develop personalized medicines.
The increasing use of cell separation technologies across the pharmaceutical industry to enhance drug discovery and development procedures represents the primary factor driving the market growth. In line with this, the growing prevalence of numerous chronic and infectious diseases, such as cancer, acquired immune deficiency syndrome (AIDS), and cystic fibrosis, is propelling the market growth. Moreover, the increasing demand for personalized and regenerative medicines is fueling the need for highly specific cell separation technologies that can isolate specific cell types for targeted therapy. Besides this, the widespread utilization of cell separation technologies in manufacturing vaccines for various diseases, including human papillomavirus (HPV), influenza, and rotavirus, is creating a favorable outlook for the market. In addition to this, extensive investments in research and development (R&D) initiatives in the flourishing biotechnology sector for developing novel cell-based treatments and therapies are contributing to the market growth. Concurrent with this, an intensive focus on stem cell research, the surging demand for in vitro diagnostics, and the implementation of numerous favorable initiatives undertaken by governments of various countries to improve healthcare infrastructure are aiding in market expansion. Furthermore, ongoing technological advancements in cell separation technologies, such as microfluidics, lab-on-a-chip, and microarray technologies, are presenting remunerative growth opportunities for the market. Furthermore, the advent of advanced isolation tools that allows continuous examination of nucleic acids, chromatin, proteins, and other complex cells is acting as another significant growth-inducing factor.
IMARC Group provides an analysis of the key trends in each sub-segment of the global cell separation technologies market report, along with forecasts at the global, regional and country level from 2024-2032. Our report has categorized the market based on product, cell type, technology, application and end user.
Instruments
Consumables
The report has provided a detailed breakup and analysis of the cell separation technologies market based on the product. This includes instruments and consumables. According to the report, consumables represented the largest segment.
Human Cells
Animal Cells
A detailed breakup and analysis of the cell separation technologies market based on the cell type has also been provided in the report. This includes human and animal cells.
Centrifugation-based Cell Separation
Surface marker-based Cell Separation
Filtration-based Cell Separation
The report has provided a detailed breakup and analysis of the cell separation technologies market based on the technology. This includes centrifugation-based, surface marker-based, and filtration-based cell separation.
Oncology Research
Neuroscience Research
Stem Cell Research
Microbiology
Immunology Research
Others
A detailed breakup and analysis of the cell separation technologies market based on the application have also been provided in the report. This includes oncology research, neuroscience research, stem cell research, microbiology, immunology research, and others.
Research Laboratories and Institute
Biotechnology and Biopharmaceutical Companies
Cell Banks
The report has provided a detailed breakup and analysis of the cell separation technologies market based on the end user. This includes research laboratories and institute, biotechnology and biopharmaceutical companies, and cell banks. According to the report, biotechnology and biopharmaceutical companies represented the largest segment.
North America
United States
Canada
Asia-Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa
The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America was the largest market for cell separation technologies. Some of the factors driving the North America cell separation technologies market included the bolstering growth of the pharmaceutical industry, the rising demand for personalized medicines, and the ongoing advancements in isolation tools.
The report has also provided a comprehensive analysis of the competitive landscape in the global cell separation technologies market. Competitive analysis such as market structure, market share by key players, player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided. Some of the companies covered include Akadeum Life Sciences, Alfa Laval AB, Becton, Dickinson and Company, Bio-Rad Laboratories Inc., Corning Incorporated, Merck KGaA, Miltenyi Biotec Inc., PerkinElmer Inc., pluriSelect Life Science UG (haftungsbeschrankt) & Co. KG, Stemcell Technologies Inc., Terumo Corporation and Thermo Fisher Scientific Inc. Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.